TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus (Q40204511)

18 September 2017

TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus (English)

1 reference

18 September 2017

0 references

0 references

1 reference

Raj Priya

1

1 reference

PubMed ID

24905288

18 September 2017

I K Patro

series ordinal

2

1 reference

PubMed ID

24905288

18 September 2017

M M Parida

series ordinal

3

1 reference

18 September 2017

4 June 2014

1 reference

18 September 2017

1 reference

18 September 2017

189

1 reference

18 September 2017

194-205

1 reference

Proteomic analysis of chikungunya virus infected microgial cells

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Neurological complications of Chikungunya virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Characterization of Chikungunya virus infection in human neuroblastoma SH-SY5Y cells: role of apoptosis in neuronal cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Peroxisomes are signaling platforms for antiviral innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

[Chikungunya in paediatrics: epidemic of 2005-2006 in Saint-Denis, Reunion Island]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The role of antibody in recovery from alphavirus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Molecular and serological diagnosis of Chikungunya virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Noncytolytic control of viral infections by the innate and adaptive immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Mouse Mx2 protein inhibits hantavirus but not influenza virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Synergistic induction of interferon α through TLR-3 and TLR-9 agonists identifies CD21 as interferon α receptor for the B cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Production, characterization, and application of monoclonal antibodies specific to recombinant (E2) structural protein in antigen-capture ELISA for clinical diagnosis of Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The earliest manifestation of focal encephalitis on diffusion-weighted MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Possible mechanisms for the transport of Semliki forest virus into and within mouse brain. An electron-microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Chikungunya, an epidemic arbovirosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Isolation and Persistence of Chikungunya Virus in Cultures of Mouse Brain Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Neurologic manifestations of pediatric chikungunya infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Development and evaluation of SYBR Green I-based one-step real-time RT-PCR assay for detection and quantification of Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Comparative full genome analysis revealed E1: A226V shift in 2007 Indian Chikungunya virus isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

A diverse range of gene products are effectors of the type I interferon antiviral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Effect of a Nuclease-Resistant Derivative of PolyriboinosinicPolyribocytidylic Acid Complex on Yellow Fever in Rhesus Monkeys (Macaca mulatta)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

[Neurological manifestations in Chikungunya: about 23 cases collected in Reunion Island].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Virus isolation as one of the diagnostic methods for dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

TLR3 deficiency in patients with herpes simplex encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2014.05.010

10.1016/J.VIRUSRES.2014.05.010

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

24905288